Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063479 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Meagan Susanne Weaver-Rosen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Molecular Genetics, UT Health, San Antonio, TX 78229, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, San Antonio Medical Foundation, Morrison Trust.
Themen: Demenz
Abstract (Originalsprache)
Amyloid-associated neurodegenerative diseases, including Alzheimer’s disease (AD), are characterized by the in-brain accumulation of β-sheet structured protein aggregates called amyloids. However, neither a disease model nor therapy is established. We review past data and present new, preliminary data and opinions to help solve this problem. The following is the data-derived model/hypothesis. (1) Amyloid-forming proteins have innate immunity functions implemented by conversion to another sheet conformation, α-sheet. (2) In health, α-sheet structured, amyloid-forming proteins inactivate microbes by co-assembly with microbe α-sheets. Amyloid-forming proteins then undergo α-to-β-sheet conversion. (3) In disease, α-sheet-structured, amyloid-forming proteins over-accumulate and are neuron-toxic. This hypothesis includes formation by virus capsid subunits of α-sheets. In support, we find that 5–10 mM methylene blue (MB) at 54 °C has a hyper-expanding, thinning effect on the phage T4 capsid, as seen by negative stain- and cryo-electron microscopy after initial detection by native gel electrophoresis (AGE). Given the reported mild anti-AD effect of MB, we propose the following corollary hypothesis. (1) Anti-AD MB activity is, at least in part, caused by MB-binding to amyloid α-sheet and (2) MB induces the transition to α-sheet of T4 capsid subunits. We propose using AGE of drug incubated T4 to test for improved anti-AD activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Molecular Genetics, UT Health, San Antonio, TX 78229, USA.
- Department of Biochemistry and Structural Biology, UT Health, San Antonio, TX 78229, USA.
ORCID-Profile: Philip Serwer
Förderung
- NCI NIH HHS
- San Antonio Medical Foundation
- Morrison Trust
- The Morrison Trust
- The San Antonio Medical Foundation
Zitieren
APA
Weaver-Rosen, M. S., & Serwer, P. (2024). Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063479
Vancouver
Weaver-Rosen MS, Serwer P. Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063479
BibTeX
@article{WeaverRosen2024,
author = {Weaver-Rosen, Meagan Susanne and Serwer, Philip},
title = {Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063479}
}
EUVIMED